亚洲免费观看高清完整版在线观看-日韩欧美二区-亚洲精品专区-96日本xxxxxⅹxxx48-久久98-亚洲激情欧美-鲁鲁在线-sm调教视频在线观看-超碰狠狠干-欧美成人午夜影院-夏目彩春娇喘呻吟高潮迭起-极品蜜桃臀肥臀-x88av-五十路毛片-中文字幕 亚洲一区-亚洲天堂一区二区三区四区

On the afternoon of May 15th, NHU held its 2023 Annual General Meeting, attended by 26 on-site shareholders and representatives, and 85 online voting shareholders. The meeting was chaired by Chairman Hu Baifan, and attended by Vice Chairman and President Hu Baishan, along with other directors, supervisors, and executives. Lawyers from Zhejiang T&C Law Firm witnessed the proceedings. All 19 motions were approved through both on-site and online voting.

Following the AGM, NHU hosted an investor exchange session, which was chaired by Ms. Shi, the secretary of the board of directors, and saw participation from over a hundred investors, including those from securities research institutions and analysts. The exchange session was divided into two parts: the first part focused on sharing NHU's development strategy and updates on the methionine and new materials businesses; the second part involved an interactive session between investors and executives, answering questions about NHU's business operations, industry development, and future plans.

NHU has consistently excelled in managing investor relations, fostering a relationship of mutual trust and aligned interests with investors. Looking ahead, NHU will continue to enhance its operations and management, adhere to innovation-driven growth, and focus on the health and new materials sectors. Leveraging the "chemical+" and "biological+" platforms, NHU aims to develop various functional chemicals and deliver better returns to shareholders and investors.